AstraZeneca COVID vaccine up to 90% effective, data shows
30 November 2020 |
3:19 pm
Though the late-stage trial results showed an efficacy of 70% on average, up to 90% of people can be prevented from getting the coronavirus if a lower dose is used. AstraZeneca said the vaccine is "highly effective."
Related
22 Dec
Christmas in Bethlehem is usually a festive and colorful season. This year, festivities in the Palestinian town are set to return — but the COVID pandemic is still casting a shadow on the celebrations.
22 Dec
German doctors and their staff have been facing aggression and threats from vaccine opponents. They have described having frayed nerves as pandemic fatigue sets in among patients and medical staff.
26 Dec
With Europe still grappling with Covid-19, Talking Europe speaks to Christa Schweng, President of the European Economic and Social Committee (EESC).
23 Dec
The ambitious goal to fully vaccinate the entire adult population is proving difficult. People are not returning to receive their second dose, and motivating them poses complex challenges.
23 Dec
Find these stories and much more when you grab a copy of The Guardian on Thursday.
25 Dec
At least one officer was injured and 11 demonstrators were arrested in an unofficial rally in Munich as police described the behavior of protesters as "aggressive."
25 Dec
The court has agreed to hear arguments about the Biden administration's vaccine or testing requirement for large employers, and a separate vaccine mandate for healthcare workers.
25 Dec
The pandemic claimed more than 600,000 lives in Brazil. But an effective vaccination campaign has turned the tide. While the pandemic may not be causing the havoc it did in the first half of 2021, it remains a major challenge.
26 Dec
The head of the World Health Organization says rich countries are merely prolonging the pandemic by fueling vaccine inequality. "No country can boost its way out of the pandemic," he says.
25 Dec
Instead, mRNA vaccines use mRNA created in a laboratory to teach our cells how to make a protein—or even just a piece of a protein—that triggers an immune response inside our bodies. That immune response, which produces antibodies, is what protects us from getting infected if the real virus enters our bodies.
23 Dec
Find these stories and much more when you grab a copy of The Guardian on Friday.
Latest
49 mins ago
Hungary's government is "holding European Union decision makers hostage" by refusing to join an EU-wide embargo on Russian oil, according to Lithuania's foreign minister. This comes as EU leaders continue their efforts to gather support for a sixth sanctions package on Russia from all 27 EU member states. The government of PM Viktor Orban has claimed that an import ban on Russian oil would ruin the Hungarian economy. Lithuania's Foreign Minister Gabrielius Landsbergis tells FRANCE 24 that "Europe is weaker" as a result, and that he is "still hoping Budapest will be responsible in their decisions".
49 mins ago
We take a look at how the press is covering Finland and Sweden saying they want to join NATO. We also discuss how the once-fringe, racist ideas of "replacement theory" have seeped through to the US Republican Party, and how they could be behind a shooting that killed 10 people in Buffalo, New York. Finally, we find out about a strange, canine bedfellow.
49 mins ago
Rising energy and commodity prices resulting from Russia's war in Ukraine are slowing Europe's economic growth and increasing inflation.
49 mins ago
At least 14 domestic tourists have been killed in a crash in East Java province. Police say there are reports the driver appeared to have been drowsy before the collision.
1 hour ago
Streaming platforms, such as Amazon Prime and Disney+, will now have to contribute money to Swiss cinema. Voters also backed switching to an opt-out system to organ donations.
1 hour ago
North Korea on Sunday reported a total of 42 deaths from "fever" after admitting its first-ever COVID-19 cases days before. Lockdown policies have been implemented across the country, according to state-run media.